2015
DOI: 10.1016/j.bios.2015.04.041
|View full text |Cite
|
Sign up to set email alerts
|

Replacing antibodies with aptamers in lateral flow immunoassay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
237
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 469 publications
(238 citation statements)
references
References 125 publications
0
237
0
1
Order By: Relevance
“…29 Aptamers have the advantages of being highly specific, relatively small in size, and easily synthesized, which could be regarded as a chemical equivalent of antibodies. 30,31 In this study, we adopted a truncated aptamer A10-3.2 with 39 nucleotides for its simplicity of chemical synthesis and enhanced specificity. It is about 55% of the full A10 in size.…”
Section: Discussionmentioning
confidence: 99%
“…29 Aptamers have the advantages of being highly specific, relatively small in size, and easily synthesized, which could be regarded as a chemical equivalent of antibodies. 30,31 In this study, we adopted a truncated aptamer A10-3.2 with 39 nucleotides for its simplicity of chemical synthesis and enhanced specificity. It is about 55% of the full A10 in size.…”
Section: Discussionmentioning
confidence: 99%
“…Aptamers have been used as 'antibody mimics' or alternatives to antibodies in some chromatographic binding assays [17][18][19][20]. These binding agents consist of single-stranded DNA or RNA sequences that are often 10 to 100 nucleotides in length and that have the ability to form highly ordered 3D structures [19].…”
Section: Antibodies and Related Binding Agentsmentioning
confidence: 99%
“…These binding agents consist of single-stranded DNA or RNA sequences that are often 10 to 100 nucleotides in length and that have the ability to form highly ordered 3D structures [19]. Aptamers are prepared through a selection and amplification process known as SELEX (i.e., the 'systematic evolution of ligands by exponential enrichment'), which can be used to generate specific binding agents with relatively high affinities for a particular target [17,18].…”
Section: Antibodies and Related Binding Agentsmentioning
confidence: 99%
See 2 more Smart Citations